Conformational Features of Beta-Amyloid Peptide 25–35

被引:0
|
作者
Agaeva G.A. [1 ]
Najafova G.Z. [2 ]
机构
[1] Institute for Physical Problems, Baku State University, Baku
[2] French-Azerbaijani University, Baku
关键词
beta-amyloid peptide 25–35; conformation; molecular dynamics method; molecular mechanics method;
D O I
10.1134/S0006350923050020
中图分类号
学科分类号
摘要
Abstract: Beta-amyloid peptide (Aβ) plays an important role in the mechanism of neurodegeneration in Alzheimer’s disease. A fragment of beta-Aβ(25–35) amyloid peptide with the sequence GSNKGAIIGLM is considered to be the functional domain of the amyloid Aβ peptide responsible for its neurotoxic properties and the biologically active Aβ region. Conformational analysis by the method of molecular mechanics of each peptide segment of the C-terminal part of the peptide revealed a limited number of the most probable conformations and clearly defined the forces stabilizing the structures. The results we obtained showed that the Aβ(25–35) peptide energetically preferentially adopts the a-helical conformation at the C-terminal octapeptide segment. The molecular dynamics method was used to model the intramolecular mobility pattern of the Aβ(25–35) peptide molecule. It is shown that in the low-energy conformations of the Aβ(25–35) peptide, the flexible structures in its N-terminal region were oriented differently with respect to the structures in the C-terminal part. © Pleiades Publishing, Inc. 2023. ISSN 0006-3509, Biophysics, 2023, Vol. 68, No. 5, pp. 712–718. Pleiades Publishing, Inc., 2023. Russian Text The Author(s), 2023, published in Biofizika, 2023, Vol. 68, No. 5, pp. 871–877.
引用
收藏
页码:712 / 718
页数:6
相关论文
共 50 条
  • [21] The protective effect of trihexyphenidyl on the beta-amyloid peptide 25-35-induced cytotoxicity in PC12 cells
    Liu, Zhen-Zhen
    Ji, Bian-Sheng
    CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 10 (04) : 237 - 243
  • [22] Beta-amyloid peptide: A calcium antagonist?
    Palotas, A
    Kalman, J
    Palotas, M
    Juhasz, A
    Janka, Z
    Penke, B
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S390 - S391
  • [23] Channel formation by a neurotoxic beta amyloid peptide, A beta 25-35
    Lin, MC
    Mirzabekov, T
    Kagan, B
    NEURODEGENERATIVE DISEASES: MOLECULAR AND CELLULAR MECHANISMS AND THERAPEUTIC ADVANCES, 1996, : 331 - 336
  • [24] The protective effect of trihexyphenidyl on the beta-amyloid peptide 25–35-induced cytotoxicity in PC12 cells
    Zhen-Zhen Liu
    Bian-Sheng Ji
    Clinical and Experimental Medicine, 2010, 10 : 237 - 243
  • [25] Administration of Aggregated Beta-Amyloid Peptide (25–35) Induces Changes in Long-Term Potentiation in the Hippocampus in Vivo
    V. V. Trubetskaya
    M. Yu. Stepanichev
    M. V. Onufriev
    N. A. Lazareva
    V. A. Markevich
    N. V. Gulyaeva
    Neuroscience and Behavioral Physiology, 2003, 33 (2) : 95 - 98
  • [26] INTERLEUKIN-1-BETA DISSOCIATES BETA-AMYLOID PRECURSOR PROTEIN AND BETA-AMYLOID PEPTIDE SECRETION
    VASILAKOS, JP
    CARROLL, RT
    EMMERLING, MR
    DOYLE, PD
    DAVIS, RE
    KIM, KS
    SHIVERS, BD
    FEBS LETTERS, 1994, 354 (03) : 289 - 292
  • [27] INTRACEREBRAL BETA-AMYLOID(25-35) PRODUCES TISSUE-DAMAGE - IS IT NEUROTOXIC
    RUSH, DK
    ASCHMIES, S
    MERRIMAN, MC
    NEUROBIOLOGY OF AGING, 1992, 13 (05) : 591 - 594
  • [28] Conformations and Biological Activities of Amyloid Beta Peptide 25-35
    Millucci, L.
    Ghezzi, L.
    Bernardini, G.
    Santucci, A.
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2010, 11 (01) : 54 - 67
  • [29] BETA-AMYLOID (25-35) FORMS CONGO RED POSITIVE AGGREGATES INVITRO
    LEE, JM
    LORENS, SA
    GUJRATI, M
    THOMAS, C
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (03): : 307 - 307
  • [30] Administration of aggregated beta-amyloid peptide (25-35) induces changes in long-term potentiation in hippocampus in vivo
    Trubetskaya, VV
    Stepanichev, MY
    Onufriev, MV
    Lazareva, NA
    Markevich, VA
    Gulyaeva, NV
    ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA, 2001, 51 (06) : 690 - 693